Atrial natriuretic peptide levels in rheumatic mitral regurgitation and response to angiotensin-converting enzyme inhibitors

Canadian Journal of Cardiology

Volumn 19, Issue 4, 2003, Pages 405-408

  Kula, Serdar ^a   Tunaoglu, F Sedef ^a   Olgunturk, Rana ^a   Gokcora, Nahide ^a  

^a GAZI UNIVERSITY   (Turkey)

Author keywords

Angiotensin converting enzyme inhibitors; Atrial natriuretic peptide; Rheumatic mitral regurgitation

Indexed keywords

ATRIAL NATRIURETIC FACTOR; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL;

ADOLESCENT; ADULT; AORTA; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLE; DISEASE COURSE; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG RESPONSE; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE VOLUME; HEART STROKE VOLUME; HEART VENTRICLE OVERLOAD; HUMAN; MALE; MITRAL VALVE; MITRAL VALVE REGURGITATION; PROTEIN BLOOD LEVEL; RHEUMATIC HEART DISEASE; SCHOOL CHILD; SYSTOLE;

ADOLESCENT; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ATRIAL NATRIURETIC FACTOR; CASE-CONTROL STUDIES; CHILD; DIGOXIN; ECHOCARDIOGRAPHY; FEMALE; HUMANS; MALE; MITRAL VALVE INSUFFICIENCY; RHEUMATIC HEART DISEASE; STROKE VOLUME; TREATMENT OUTCOME; VENTRICULAR FUNCTION, LEFT;

EID: 0038629385     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. El-Said GM, El-Reface MM. Rheumatic heart disease. In: Garson A, Bricker JT, McNamara DG, eds. The Science and Practice of Pediatric Cardiology. Philadelphia: Lea & Febiger, 1990:1502-26.
2. Kikuchi K, Nishioka K, Ueda T, et al. Relationship between plasma atrial natriuretic peptide concentration and hemodynamic measurements in children with congenital heart disease. J Pediatr 1987;111:333-42.
3. Perrella MA, Margulies KB, Burnett JC. Pathophysiology of congestive heart failure: Role of atrial natriuretic factor and therapeutic implications. Can J Physiol Pharmacol 1991;69:1576-81.
4. Saito Y, Nakao K, Nishimura K, et al. Clinical application of atrial natriuretic polypeptide in patients with congestive heart failure: Beneficial effects on left ventricular function. Circulation 1987;76:115-24.
5. Moe GW, Grima EA, Wong NL, Howard RJ, Armstrong PW. Plasma and cardiac tissue atrial and brain natriuretic peptides in experimental heart failure. J Am Coll Cardiol 1996;27:720-7.
6. Dickstein K, Abrahamsen S, Aarsland T. Plasma N-terminal atrial natriuretic peptide predicts hospitalization in patient with heart failure. Scand Cardiovasc J 1998;32:361-4.
7. Lerman A, Gibbons RJ, Rodeheffer RJ, et al. Circulating N-terminal atrial natriuretic peptide as a marker for symptomless left-ventricular dysfunction. Lancet 1993;341:1105-9.
8. Perrella MA, Schwab TR, O'Murchu B, et al. Cardiac atrial natriuretic factor during evolution of congestive heart failure. Am J Physiol 1992;262:H1248-55.
9. Sagnella GA. Measurement and significance of circulating natriuretic peptides in cardiovascular disease. Clin Sci 1998;95:519-29.
10. Yamamoto K, Burnett JC Jr, Bermudez EA, et al. Clinical criteria and biochemical markers for the detection of systolic dysfunction. J Card Fail 2000;6:194-200.
11. Cowie MR. BNP: Soon to become a routine measurement in the care of the patients with heart failure? Heart 2000;83:617-8.
12. Yoshimura M, Yasue H, Morita E, et al. Hemodynamic, renal and hormonal responses to brain natriuretic peptide infusio in patients with congestive heart failure. Circulation 1991;84:1581-8.
13. Kitashiro S, Sugiura T, Takayama Y, et al. Long-term administration of atrial natriuretic peptide in patients with acute heart failure. J Cardiovasc Pharmacol 1999;33:948-52.
14. Francis GS, Benedict C, Johnstone DE, et al. Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure: A substudy of the Studies of Left Ventricular Dysfunction (SOLVD). Circulation 1990;82:1724-9.
15. Yasue H, Yoshimura M. Natriuretic peptides in the treatment of heart failure. J Card Fail 1996;2(4 Suppl):S277-85.
16. Richards AM, Nicholls MG, Ikram H, Webster MW, Yandle TG, Espiner EA. Renal, haemodynamic and hormonal effects of human alpha atrial natriuretic peptide in healthy volunteers. Lancet 1985;i:545-9.
17. Berglund H, Nyquist O, Beermann B, Jensen-Urstad M, Theodorsson E. Influence of angiotensin converting enzyme inhibition on relation of atrial natriuretic peptide concentration to atrial pressure in heart failure. Br Heart J 1994;72:521-7.
18. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. The SOLVD Investigators. N Engl J Med 1992;327:685-91.